(Q39014333)

8 September 2017

Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease (English)

1 reference

8 September 2017

1 reference

1 reference

10

Kazunori Oishi

1 reference

8 September 2017

Akitsugu Furumoto

1

1 reference

8 September 2017

Yasushi Ohkusa

2

1 reference

8 September 2017

Meng Chen

3

1 reference

8 September 2017

Kenji Kawakami

4

1 reference

8 September 2017

Hironori Masaki

5

1 reference

8 September 2017

Yoshiko Sueyasu

6

1 reference

8 September 2017

Tomoaki Iwanaga

7

1 reference

8 September 2017

Hisamichi Aizawa

8

1 reference

8 September 2017

Tsuyoshi Nagatake

9

1 reference

8 September 2017

language of work or name

English

0 references

publication date

5 June 2008

1 reference

8 September 2017

1 reference

8 September 2017

26

1 reference

8 September 2017

33

1 reference

8 September 2017

4284-4289

1 reference

Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Respiratory viral infections in adults with and without chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Natural and vaccine-related immunity to Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Pneumococcal vaccines: history, current status, and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Pneumococcal vaccine and patients with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Increased prevalence of pediatric pneumococcal serotypes in elderly adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Acute exacerbation of COPD: factors associated with poor treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Impact of COPD exacerbations on patient-centered outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

A role for Streptococcus pneumoniae in virus-associated pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Influenza virus neuraminidase contributes to secondary bacterial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Lung Fluid Immunoglobulin from HIV-Infected Subjects Has Impaired Opsonic Function against Pneumococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.037

10.1016/J.VACCINE.2008.05.037

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference